Metabolites 13, 633
Lee, Sherman and Latham moved to Atlantic Studios on August 21st, where the former two continued editing and comping while Latham mixed
doi: 10.1016/j.ecoenv.2024.116680 45 ChenZTangHGanSYangCLiSLiJet al
In sum, our data document the beneficial effects of GLP1-based multi-agonists, and particularly GLP1/E, in two models of PCOS, with the identification of optimal doses, main metabolic and reproductive effects, and tenable hypothalamic pathways targeted
[1] [3] Beyond glycemic control, these medications slow gastric emptying, which prolongs satiety and reduces appetite through central nervous system pathways
"The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents"